Clinical trial examines safety, effectiveness of drug to treat binge eating disorder

At some doses, the medication lisdexamfetamine dimesylate, a drug approved to treat attention-deficit/hyperactivity disorder, was effective compared with placebo in decreasing binge-eating days in patients with binge-eating disorder, a public health problem associated symptoms of mental illness and obesity and for which there are no approved medications, according to a study.

Read the whole article on Science Daily

More from Science Daily